P-Anisidine → HCID 66592614, compound
Reaction equation
Cl[C:2]1[CH:3]=[C:4]([C:8]2[N:12]3[CH:13]=[CH:14][CH:15]=[CH:16][C:11]3=[N:10][CH:9]=2)[CH:5]=[CH:6][CH:7]=1.[CH3:17][O:18][C:19]1[CH:24]=[CH:23][C:22]([NH2:25])=[CH:21][CH:20]=1.CC(C)([O-])C.[Na+]>C1(C)C=CC=CC=1>[N:10]1[CH:9]=[C:8]([C:4]2[CH:3]=[C:2]([C:23]3[CH:24]=[C:19]([O:18][CH3:17])[CH:20]=[CH:21][C:22]=3[NH2:25])[CH:7]=[CH:6][CH:5]=2)[N:12]2[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=12Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 110 °C
Procedure
A mixture of 3-(3-Chloro-phenyl)-imidazo[1,2-a]pyridine (183 mg, 0.8 mmol), 4-Methoxy-phenylamine (200 mg, 1.6 mmol) and sodium tertbutoxide (195 mg, 2 mmol) in dry toluene (3 ml) was deoxygenated. 2′-(Dimethylamino)-2-biphenylyl-palladium(II) chloride dinorbornylphosphine complex (45 mg, 0.08 mmol) was added and the reaction mixture deoxygenated again, then heated at 110° C. for 2 h. The mixture was allowed to cool, then partitioned between CH2Cl2 and H2O and separated using a phase separating cartridge. The organic solvent was removed in vacuo and the residue purified by column chromatography, then preparative HPLC to give the desired compound (25 mg).
Workup
- customwas deoxygenated
- addition2′-(Dimethylamino)-2-biphenylyl-palladium(II) chloride dinorbornylphosphine complex (45 mg, 0.08 mmol) was added
- customthe reaction mixture deoxygenated again
- temperatureto cool
- custompartitioned between CH2Cl2 and H2O
- customseparated
- customseparating cartridge
- customThe organic solvent was removed in vacuo
- customthe residue purified by column chromatography
Sources & evidence
- ORD record
- ord-f886d900a9904e3db1a0d7a2c61453af
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08131527B1
Reaction notes
Loading…